Financial & Business News

Lumen (LUMN -0.70%) stock closed out this week's trading with big gains. The company's share price surged 7.8% higher compared to where it stood at market close on Friday of the previous week.

Sonoco's transformation via M&A and debt reduction is progressing, but near-term results are weighed down by integration challenges and higher interest expenses. Organic growth and margin expansion are encouraging, yet European softness and working capital seasonality create headwinds and investor skepticism. Management's guidance credibility is under pressure due to underestimating working capital and interest expense impacts, but long-term leverage targets remain achievable.

The S&P 500 has long been the stock market's most followed and important index. Tracking 500 of the largest American companies on the market, it's often used to gauge the health of the U.S. economy and market.

American Tower's slow growth and lofty valuation make it unattractive compared to broader market returns, despite its stability and strong dividend yield. AFFO per share growth is minimal, barely outpacing inflation, and revenue growth is largely driven by FX variations rather than core business expansion. High leverage and capital obligations limit flexibility, and rising interest rates could pressure future cash flows and shareholder returns.

For years, ExxonMobil Corp (XOM 0.82%) was stuck in limbo. In 2007, for instance, Exxon stock traded at roughly $85 per share.

The August jobs report and earnings from companies including Salesforce and Broadcom are among the top events set for a trading week shortened by the Labor Day holiday.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced results of new analyses from the HELIOS-B Phase 3 study of AMVUTTRA® (vutrisiran), an RNAi therapeutic approved for the treatment of the cardiomyopathy of wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM) in adults. Data from the 12-month follow-up of the ongoing open-label extension (OLE) period of HELIOS-B were presented during an oral sess.

Uber (UBER -2.28%) is simultaneously increasing engagement with existing customers and attracting new ones.

The tech-driven bull market has driven up valuations for tech stocks, but this could present long-term investors attractive buying opportunities for top stocks in the consumer goods space.

Professional Diversity Network (NASDAQ: IPDN) was the star of the market on Friday after its share price surged more than 200%, making it the day's top gainer.